H. Lundbeck A/S (OTCMKTS:HLUYY) Trading Down 0% – Should You Sell?

by · The Cerbat Gem

H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares were down 0% on Monday . The stock traded as low as $22.00 and last traded at $22.00. Approximately 7,500 shares were traded during trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.01.

H. Lundbeck A/S Stock Performance

The company has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The stock’s fifty day simple moving average is $22.00 and its 200-day simple moving average is $22.00.

About H. Lundbeck A/S

(Get Free Report)

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.

Featured Stories